Ovarian Cancer, Childhood Clinical Trials

• TLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00022347 - Active, not recruiting
  ovarian serous cystadenocarcinoma; recurrent ovarian epithelial cancer; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ...
  
• Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00003322 - Active, not recruiting
  ovarian serous cystadenocarcinoma; stage III ovarian epithelial cancer; ovarian clear cell cystadenocarcinoma; recurrent ovarian epithelial cancer; ...
  
• Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission
  ClinicalTrials.gov Identifier: NCT00002977 - Active, not recruiting
  ovarian serous cystadenocarcinoma; stage III ovarian epithelial cancer; ovarian clear cell cystadenocarcinoma; stage IV ovarian epithelial cancer; ...
  
• Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00091273 - Active, not recruiting
  stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
  
• Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas
  ClinicalTrials.gov Identifier: NCT00012181 - Active, not recruiting
  childhood bone cancer; childhood brain cancer; childhood eye cancer; childhood kidney tumors; childhood non-Hodgkin's lymphoma; ...
  
• Amifostine to Protect From the Side Effects of Peripheral Stem Cell Transplantation in Treating Patients With High-Risk or Relapsed Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003926 - Active, not recruiting
  childhood soft tissue sarcoma; childhood liver cancer; adult soft tissue sarcoma; Bone Cancer; ovarian sarcoma; Testicular Cancer; Brain Tumor; ...
  
• Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers
  ClinicalTrials.gov Identifier: NCT00002538 - Active, not recruiting
  ovarian serous cystadenocarcinoma; stage III ovarian epithelial cancer; ovarian clear cell cystadenocarcinoma; stage I ovarian epithelial cancer; ...
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00005612 - Active, not recruiting
  recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00005026 - Active, not recruiting
  ovarian serous cystadenocarcinoma; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ovarian mixed epithelial carcinoma; ...
  
• Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00002568 - Active, not recruiting
  ovarian serous cystadenocarcinoma; stage III ovarian epithelial cancer; ovarian clear cell cystadenocarcinoma; ovarian endometrioid adenocarcinoma; ...
  
• Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00017303 - Active, not recruiting
  ovarian serous cystadenocarcinoma; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ovarian mixed epithelial carcinoma; ...
  
• Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00003967 - Active, not recruiting
  ovarian serous cystadenocarcinoma; recurrent ovarian epithelial cancer; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ...
  
• Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy
  ClinicalTrials.gov Identifier: NCT00004115 - Active, not recruiting
  stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00003944 - Active, not recruiting
  ovarian serous cystadenocarcinoma; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ovarian mixed epithelial carcinoma; ...
  
• Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00002477 - Active, not recruiting
  stage I ovarian epithelial cancer; stage II ovarian epithelial cancer
  
• Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00101257 - Active, not recruiting
  recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00003413 - Active, not recruiting
  recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; Quality of Life
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00003297 - Active, not recruiting
  recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Tariquidar Plus Chemotherapy in Treating Children With Relapsed or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00020514 - Active, not recruiting
  Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Kidney Cancer; Liver Cancer; Neuroblastoma; Ovarian Cancer; Sarcoma; Unspecified Childhood Solid Tumor, Protocol Specific
  
• Comparison of Combination Chemotherapy Regimens in Treating Newly Diagnosed Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00028743 - Active, not recruiting
  stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; Fallopian Tube Cancer; ...
  
• Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy
  ClinicalTrials.gov Identifier: NCT00004166 - Active, not recruiting
  stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
  
• Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00003733 - Active, not recruiting
  stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00002717 - Active, not recruiting
  ovarian serous cystadenocarcinoma; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ovarian mixed epithelial carcinoma; ...
  
• Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00003358 - Active, not recruiting
  recurrent ovarian epithelial cancer; stage I ovarian epithelial cancer; peritoneal cavity cancer; stage II ovarian epithelial cancer; ...
  
• Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00034151 - Active, not recruiting
  Ovarian Cancer
  
• Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00021385 - Active, not recruiting
  recurrent ovarian germ cell tumor; recurrent ovarian epithelial cancer; stage III ovarian germ cell tumor; stage IV ovarian germ cell tumor; ...
  
• Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00041080 - Active, not recruiting
  stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; Fallopian Tube Cancer; ...
  
• Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum
  ClinicalTrials.gov Identifier: NCT00003160 - Active, not recruiting
  stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer; ...
  
• Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects with Relapsed or Refractory Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00113789 - Active, not recruiting
  Ovarian Cancer
  
• National Ovarian Cancer Early Detection Program Screening and Genetic Study
  ClinicalTrials.gov Identifier: NCT00005095 - Recruiting
  stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
  
• Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00003994 - Active, not recruiting
  stage I childhood liver cancer; recurrent childhood liver cancer; childhood hepatoblastoma
  
• Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00006230 - Active, not recruiting
  stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer
  
• Vaccine Therapy in Treating Patients With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00066729 - Active, not recruiting
  stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer; ...
  
• Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00006942 - Active, not recruiting
  stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; Fallopian Tube Cancer; ...
  
• Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00003345 - Active, not recruiting
  stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; stage I ovarian epithelial cancer; ...
  
• Carboplatin and Paclitaxel With or Without Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00052468 - Active, not recruiting
  stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
  
• Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00021034 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer; stage II ovarian epithelial cancer; Fallopian Tube Cancer; ...
  
• 3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00081276 - Active, not recruiting
  recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer
  
• Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00058435 - Active, not recruiting
  stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; ...
  
• Carboplatin With or Without Liposomal Doxorubicin in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00043082 - Active, not recruiting
  peritoneal cavity cancer; recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00003532 - Active, not recruiting
  stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; stage III ovarian germ cell tumor; ...
  
• Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00031954 - Active, not recruiting
  stage I ovarian epithelial cancer; peritoneal cavity cancer; stage II ovarian epithelial cancer; Fallopian Tube Cancer; ...
  
• Hormone Therapy With LY353381 Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00003670 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer; stage IV ovarian epithelial cancer
  
• Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00003998 - Active, not recruiting
  stage I ovarian epithelial cancer; peritoneal cavity cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; ...
  
• A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment
  ClinicalTrials.gov Identifier: NCT00421889 - Recruiting
  Ovarian Cancer; Epithelial Ovarian Cancer; Fallopian Tube Cancer
  
• Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00003214 - Active, not recruiting
  Ovarian Cancer
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00004221 - Active, not recruiting
  ovarian serous cystadenocarcinoma; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ovarian mixed epithelial carcinoma; ...
  
• Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00030706 - Active, not recruiting
  stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Quality-of-Life Assessment in Patients With Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00003772 - Active, not recruiting
  recurrent ovarian epithelial cancer; stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; ...
  
• Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00004064 - Active, not recruiting
  stage I ovarian epithelial cancer; peritoneal cavity cancer; stage II ovarian epithelial cancer; Fallopian Tube Cancer; ...
  
• High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation and Chemoprotective Therapy in Treating Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00003425 - Active, not recruiting
  Leukemia; Bone Cancer; ovarian sarcoma; ovarian epithelial cancer; Lymphoma; Breast Cancer; Multiple Myeloma
  
• Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy
  ClinicalTrials.gov Identifier: NCT00084370 - Active, not recruiting
  ovarian epithelial cancer
  
• Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00004876 - Recruiting
  stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission
  ClinicalTrials.gov Identifier: NCT00003120 - Active, not recruiting
  stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer; ...
  
• Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00053833 - Active, not recruiting
  recurrent ovarian epithelial cancer; Fallopian Tube Cancer; peritoneal cavity cancer; stage III ovarian epithelial cancer; ...
  
• Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00003450 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer; stage IV ovarian epithelial cancer
  
• Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
  ClinicalTrials.gov Identifier: NCT00003170 - Active, not recruiting
  Pancreatic Cancer; Vulvar Cancer; Renal Cell Cancer; Endometrial Cancer; Testicular Cancer; ovarian epithelial cancer; Colon Cancer; Rectal Cancer; ...
  
• A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects with Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00096993 - Active, not recruiting
  Ovarian Cancer; Peritoneal Cancer
  
• Bevacizumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00022659 - Active, not recruiting
  stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00563836 - Recruiting
  Ovarian Cancer; Epithelial Ovarian Cancer
  
• Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00003378 - Active, not recruiting
  peritoneal cavity cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Imatinib Mesylate in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00036751 - Active, not recruiting
  stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Second-Line Treatment for Patients with Platinum-Sensitive Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00090610 - Recruiting
  Ovarian Cancer
  
• Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00010179 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer; stage III ovarian epithelial cancer; ...
  
• Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00155896 - Recruiting
  Ovarian Cancer
  
• Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00011986 - Active, not recruiting
  stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer
  
• Chemotherapy in Treating Children With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00003912 - Active, not recruiting
  childhood hepatoblastoma; childhood hepatocellular carcinoma; childhood liver cancer
  
• Combination Chemotherapy in Treating Patients With Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00019045 - Active, not recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Fenretinide in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00026091 - Active, not recruiting
  stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00006036 - Active, not recruiting
  Lung Cancer; lip and oral cavity cancer; Head and Neck Cancer; ovarian sarcoma; ovarian epithelial cancer; Oropharyngeal Cancer
  
• CA 125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00058032 - Active, not recruiting
  ovarian epithelial cancer
  
• Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00501644 - Active, not recruiting
  Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer
  
• Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk
  ClinicalTrials.gov Identifier: NCT00017134 - Active, not recruiting
  ovarian epithelial cancer
  
• A Study to Evaluate the effect of HER2 Activation on rhuMAb 2C4 (pertuzumab) in Subjects with Advanced Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00058552 - Active, not recruiting
  Ovarian Cancer
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00003136 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00003892 - Active, not recruiting
  recurrent ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00045682 - Active, not recruiting
  peritoneal cavity cancer; recurrent ovarian epithelial cancer
  
• Screening for Cancer of the Prostate, Lung, Colon, Rectum, or Ovaries in Older Patients
  ClinicalTrials.gov Identifier: NCT00002540 - Active, not recruiting
  screening for prostate cancer; ovarian germ cell tumor; Small Cell Lung Cancer; ovarian epithelial cancer; screening for ovarian cancer; ...
  
• Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00053352 - Recruiting
  childhood malignant ovarian germ cell tumor; childhood extragonadal malignant germ cell tumor; childhood malignant testicular germ cell tumor
  
• Cediranib in Treating Young Patients With Refractory or Recurrent Solid Tumors or Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00354848 - Recruiting
  Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Kidney Cancer; Leukemia; Liver Cancer; Ovarian Cancer; Sarcoma; Unspecified Childhood Solid Tumor, Protocol Specific
  
• Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00005025 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
  
• Yoga in Controlling Symptoms and Reducing Stress in Women With Ovarian Cancer or Breast Cancer
  ClinicalTrials.gov Identifier: NCT00337233 - Active, not recruiting
  Breast Cancer; Fatigue; Ovarian Cancer; Psychosocial Effects/Treatment
  
• Carboplatin in Treating Patients With Stage IC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00098878 - Recruiting
  stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
  
• OVATURE (OVArian TUmor REsponse) Study: A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00382811 - Recruiting
  Fallopian Tube Cancer; Peritoneal Neoplasms; Ovarian Cancer
  
• A Study Comparing the Combination of Doxil and Yondelis, to Doxil Alone for Subjects with Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00113607 - Active, not recruiting
  Ovarian Cancer
  
• Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00006454 - Active, not recruiting
  stage II ovarian epithelial cancer; Fallopian Tube Cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• PXD101 in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors
  ClinicalTrials.gov Identifier: NCT00301756 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Liposomal Cisplatin in Treating Patients With Recurrent Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00004083 - Active, not recruiting
  stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer
  
• Biological Therapy in Treating Patients With Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00004604 - Active, not recruiting
  Lung Cancer; Testicular Cancer; ovarian epithelial cancer; Pancreatic Cancer; Colon Cancer; Thyroid Cancer; Gastric Cancer; Salivary Gland Cancer; ...
  
• Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00002894 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer
  ClinicalTrials.gov Identifier: NCT00032162 - Active, not recruiting
  Cervical Cancer; Endometrial Cancer; Fallopian Tube Cancer; uterine sarcoma; ovarian sarcoma; ovarian carcinosarcoma
  
• Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00075543 - Active, not recruiting
  recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00383279 - Active, not recruiting
  Cervical Cancer; Ovarian Cancer; Sarcoma
  
• Safety and Efficacy Study of Panzem® Nanocrystal Colloidal Dispersion in Patients With Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00400348 - Active, not recruiting
  Ovarian Cancer
  
• MITO-5: Weekly Carboplatin and Paclitaxel as First Line Chemotherapy for Elderly Patients With Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00401674 - Active, not recruiting
  Ovarian Cancer
  
• Safety, Tolerability and Pharmacokinetics of MORAb-003 in Subjects With Advanced Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00428766 - Active, not recruiting
  Epithelial Ovarian Cancer
  
• Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
  ClinicalTrials.gov Identifier: NCT00126542 - Active, not recruiting
  recurrent ovarian epithelial cancer; stage IV ovarian epithelial cancer; Fallopian Tube Cancer; peritoneal cavity cancer
  
• Safety and Efficacy Study of the Trifunctional Antibody Catumaxomab to Treat Ovarian Cancer in Women After a Complete Response to Chemotherapy
  ClinicalTrials.gov Identifier: NCT00377429 - Active, not recruiting
  Ovarian Cancer
  
• Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00003385 - Active, not recruiting
  Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
  
• A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00461786 - Active, not recruiting
  Ovarian Cancer; Peritoneal Cancer